EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieÄquivalenzstudieOpen Access

Sirolimus-coated versus paclitaxel-coated balloons for bifurcated coronary lesions in the side branch: the SPACIOUS trial

You Zhou, Yiqing Hu, Xin Zhao, Zhangwei Chen, Chenguang Li, Likun Ma, Zongjun Liu, Hao Zhou, Xiwen Zang, Xingwei Zhang, Gaoxing Zhang, Zhanqian Cui und 8 weitere

EuroIntervention · 2025-03 · 21 (6) · e307-e317

DOI: 10.4244/eij-d-24-00742 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift EuroIntervention, 2025-03. Verfasst von You Zhou und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Geriatric Medical Center, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Sha…. Hauptthemen laut MEDLINE: Paclitaxel, Sirolimus, Angioplasty, Balloon, Coronary, Coronary Artery Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The optimal strategy to treat coronary bifurcation lesions (CBL) has been a long-debated topic. The combination of a stent in the main vessel (MV) and a drug-coated balloon (DCB) in the side branch (SB) seems promising, but the evidence is limited. AIMS: This study aims to investigate a novel sirolimus-coated balloon in the treatment of non-left main CBL compared with a paclitaxel-coated balloon. METHODS: The SPACIOUS trial is a prospective, non-inferiority, multicentre trial. A total of 230 patients were randomised to the sirolimus DCB or the paclitaxel DCB group in a 1:1 ratio. Angiographic and clinical follow-ups were planned at 9 months and 1 year, respectively. The primary endpoint was diameter stenosis (DS) in the SB at 9 months. RESULTS: At 9 months, DS in the sirolimus group was 30.5±16.1% compared with 33.5±16.2% in the paclitaxel group (difference -2.94%; 95% confidence interval: -7.62% to 1.74%; p for non-inferiority

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelSirolimusAngioplasty, Balloon, CoronaryCoronary Artery DiseaseCoronary StenosisHumansMaleFemaleMiddle AgedAgedProspective StudiesTreatment OutcomeCoronary AngiographyDrug-Eluting StentsCoronary RestenosisPercutaneous Coronary InterventionCardiovascular AgentsCoated Materials, Biocompatible

Substanzen

PaclitaxelSirolimusCardiovascular AgentsCoated Materials, Biocompatible

Autor:innen und Institutionen

  • Department of Cardiology, Shanghai Geriatric Medical Center, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China; National Clinical Research Center for Interventional Med…
  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China; National Clinical Research Center for Interventional Medicine, Shanghai, China; State Key L…
  • Department of Cardiology, Anhui Provincial Hospital, Hefei, China.
  • Department of Cardiology, Shanghai Putuo District Central Hospital, Shanghai, China.
  • Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • TEDA International Cardiovascular Hospital, Tianjin, China.

Zitieren

APA

Zhou, Y., Hu, Y., Zhao, X., Chen, Z., Li, C., Ma, L., Liu, Z., Zhou, H., Zang, X., Zhang, X., Zhang, G., Cui, Z., Liu, Y., Han, S., Wu, L., Shi, H., Jiang, J., Qian, J., Lu, H., & Ge, J. (2025). Sirolimus-coated versus paclitaxel-coated balloons for bifurcated coronary lesions in the side branch: the SPACIOUS trial. EuroIntervention, 21(6), e307-e317. https://doi.org/10.4244/eij-d-24-00742

Vancouver

Zhou Y, Hu Y, Zhao X, Chen Z, Li C, Ma L, et al. Sirolimus-coated versus paclitaxel-coated balloons for bifurcated coronary lesions in the side branch: the SPACIOUS trial. EuroIntervention. 2025;21(6):e307-e317. doi:10.4244/eij-d-24-00742

BibTeX
@article{Zhou2025,
  author = {Zhou, You and Hu, Yiqing and Zhao, Xin and Chen, Zhangwei and Li, Chenguang and Ma, Likun and Liu, Zongjun and Zhou, Hao and Zang, Xiwen and Zhang, Xingwei and Zhang, Gaoxing and Cui, Zhanqian and Liu, Yin and Han, Suxia and Wu, Lianpin and Shi, Haiming and Jiang, Jianjun and Qian, Juying and Lu, Hao and Ge, Junbo},
  title = {Sirolimus-coated versus paclitaxel-coated balloons for bifurcated coronary lesions in the side branch: the SPACIOUS trial},
  journal = {EuroIntervention},
  year = {2025},
  volume = {21},
  number = {6},
  pages = {e307--e317},
  doi = {10.4244/eij-d-24-00742}
}
Kostenlos starten →